Clostridioides difficile infection (CDI) remains a significant clinical challenge both in the
management of severe and severe-complicated disease and the prevention of recurrence …

Clostridioides difficile infection (CDI) is one of the major issues in nosocomial infections.
This bacterium is constantly evolving and poses complex challenges for clinicians, often …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

Fecal microbiota transplantation (FMT) is the process of transplanting stool from a healthy
donor into the gut of a patient for therapeutic purposes. Current guidelines recommend FMT …

Clostridioides (formerly: Clostridium) difficile infection (CDI) is a major cause of diarrhoea for
inpatients as well as outpatients. Usually, CDI is healthcare-associated but the number of …

Abstract Aim: This Danish national guideline describes the treatment of adult patients with
Clostridioides (formerly Clostridium) difficile (CD) infection and the use of faecal microbiota …

Clostridioides difficile is an increasingly common pathogen both within and outside the
hospital and is responsible for a large clinical spectrum from asymptomatic carriage to …

Abstract Background Severe and fulminant Clostridioides difficile infection (CDI) is
associated with significant morbidity and mortality. While fecal microbiota transplantation …

Fulminant Clostridioides difficile infection (FCDI) encompasses 3 to 5% of all CDI cases with
associated mortality rates between 30 and 40%. Major treatment modalities include surgery …

Clostridioides difficile infection is the most common cause of infectious diarrhea in hospitals
with an increasing incidence in the community. Clinical presentation of C difficile infection …